171 related articles for article (PubMed ID: 33974272)
21. Novel insights into the disease dynamics of B-cell lymphomas in the Genomics Era.
Chan FC; Lim E; Kridel R; Steidl C
J Pathol; 2018 Apr; 244(5):598-609. PubMed ID: 29359812
[TBL] [Abstract][Full Text] [Related]
22. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
23. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
Cheng F; Hong H; Yang S; Wei Y
Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
[TBL] [Abstract][Full Text] [Related]
24. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
25. Enabling Precision Oncology Through Precision Diagnostics.
Brown NA; Elenitoba-Johnson KSJ
Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
[TBL] [Abstract][Full Text] [Related]
26. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
Elife; 2020 May; 9():. PubMed ID: 32401198
[TBL] [Abstract][Full Text] [Related]
27. Implementing precision cancer medicine in the genomic era.
Chen HZ; Bonneville R; Roychowdhury S
Semin Cancer Biol; 2019 Apr; 55():16-27. PubMed ID: 29857039
[TBL] [Abstract][Full Text] [Related]
28. The evolving field of prognostication and risk stratification in MDS: Recent developments and future directions.
Lee EJ; Podoltsev N; Gore SD; Zeidan AM
Blood Rev; 2016 Jan; 30(1):1-10. PubMed ID: 26119927
[TBL] [Abstract][Full Text] [Related]
29. The emerging clinical relevance of genomics in cancer medicine.
Berger MF; Mardis ER
Nat Rev Clin Oncol; 2018 Jun; 15(6):353-365. PubMed ID: 29599476
[TBL] [Abstract][Full Text] [Related]
30. Pathologists and liquid biopsies: to be or not to be?
Hofman P; Popper HH
Virchows Arch; 2016 Dec; 469(6):601-609. PubMed ID: 27553354
[TBL] [Abstract][Full Text] [Related]
31. KRAS mutation testing in colorectal cancer as an example of the pathologist's role in personalized targeted therapy: a practical approach.
Domagała P; Hybiak J; Sulżyc-Bielicka V; Cybulski C; Ryś J; Domagała W
Pol J Pathol; 2012 Nov; 63(3):145-64. PubMed ID: 23161231
[TBL] [Abstract][Full Text] [Related]
32. Exploiting rare driver mutations for precision cancer medicine.
Scholl C; Fröhling S
Curr Opin Genet Dev; 2019 Feb; 54():1-6. PubMed ID: 30844512
[TBL] [Abstract][Full Text] [Related]
33. The emerging significance of secondary germline testing in cancer genomics.
Mandelker D; Zhang L
J Pathol; 2018 Apr; 244(5):610-615. PubMed ID: 29293272
[TBL] [Abstract][Full Text] [Related]
34. The value of cell-free DNA for molecular pathology.
Stewart CM; Kothari PD; Mouliere F; Mair R; Somnay S; Benayed R; Zehir A; Weigelt B; Dawson SJ; Arcila ME; Berger MF; Tsui DW
J Pathol; 2018 Apr; 244(5):616-627. PubMed ID: 29380875
[TBL] [Abstract][Full Text] [Related]
35. Tumor Evolution, Heterogeneity, and Therapy for Our Patients With Advanced Cancer: How Far Have We Come?
El-Deiry WS; Taylor B; Neal JW
Am Soc Clin Oncol Educ Book; 2017; 37():e8-e15. PubMed ID: 28746017
[TBL] [Abstract][Full Text] [Related]
36. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies.
Aardema MJ; MacGregor JT
Mutat Res; 2002 Jan; 499(1):13-25. PubMed ID: 11804602
[TBL] [Abstract][Full Text] [Related]
37. [Precision Medicine in Obesity Research and Practice].
Li SY; Li SQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):1-6. PubMed ID: 28612549
[TBL] [Abstract][Full Text] [Related]
38. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
[TBL] [Abstract][Full Text] [Related]
39. A decision support framework for genomically informed investigational cancer therapy.
Meric-Bernstam F; Johnson A; Holla V; Bailey AM; Brusco L; Chen K; Routbort M; Patel KP; Zeng J; Kopetz S; Davies MA; Piha-Paul SA; Hong DS; Eterovic AK; Tsimberidou AM; Broaddus R; Bernstam EV; Shaw KR; Mendelsohn J; Mills GB
J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25863335
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]